Thus, oral supplementation with N-acetylcysteine (NAC) or vitamin E after the induction of lung cancer has been reported to increase tumor progression and to reduce survival in both B-RAF- and K-RAS-induced mouse models of lung cancer [3]. This evidence concerns the gene KRAS and lung carcinoma.